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In this paper, we report the design of a new nanofluid for anti-pathogenic surface coating. For this purpose, new
2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl)-benzamides were synthesized and used as an
adsorption shell for Fe3O4/C12 core/shell nanosized material. The functionalized specimens were tested by in vitro
assays for their anti-biofilm properties and biocompatibility. The optimized catheter sections showed an improved
resistance to Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 27853 in vitro biofilm
development, as demonstrated by the viable cell counts of biofilm-embedded bacterial cells and by scanning
electron microscopy examination of the colonized surfaces. The nanofluid proved to be not cytotoxic and did not
influence the eukaryotic cell cycle. These results could be of a great interest for the biomedical field, opening new
directions for the design of film-coated surfaces with improved anti-biofilm properties.
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In the recent years, the emergence of resistance and
multiresistance to antimicrobial substances has led to in-
creasing concerns and interests in finding new anti-
microbial agents and identifying new strategies for the
treatment of infectious diseases [1-4]. Thiourea deriva-
tives possess many biological activities, including anti-
microbial activity, having interesting applications in
numerous fields (in agriculture, as ligands useful in co-
ordination chemistry, in analytical chemistry, in anion
recognition, and in catalysis).
The synthesis and antibacterial activity of thiourea
derivatives has been the subject of numerous investiga-
tions. Some new substituted 1,3,5-triazine with 1,2,4-* Correspondence: grumezescu@yahoo.com
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in any medium, provided the original work is ptriazole and substituted thiourea and urea were previ-
ously synthesized and evaluated for their in vitro inhibi-
tory activity against Staphylococcus aureus, Bacillus
subtilis, Escherichia coli, Pseudomonas aeruginosa, and
Candida albicans, some of them showing excellent anti-
microbial activity [5].
Sarmah and coworkers synthesized and characterized
new compounds using the substitution of chlorine in
cyanuric chloride by some moieties with biological im-
portance, such as substituted thiourea and heterocyclic
systems, in order to achieve enhanced antimicrobial ac-
tivity against different bacterial and fungal strains,
favored by the presence of electron-withdrawing groups
on the aromatic ring as compared to compounds with
electron-donating groups [6]. The (E)-N-[4-(benzamido-
methyleneamino)phenylcarbamothioyl]benzamide
synthesized by Kurt et al. exhibited in vitro antibacterial
activity against B. subtilis [7].an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Anghel et al. Nanoscale Research Letters 2012, 7:513 Page 2 of 10
http://www.nanoscalereslett.com/content/7/1/513The biological significance of thioureas and 2-
aminobenzothiazoles stimulated research to investigate
the synergistic effects of these moieties to afford the
design of a new class of heterocyclic thioureas. The new
1-aroyl-3-(substituted-2-benzothiazolyl)-thioureas were
found to exhibit moderate to potent activity towards S.
aureus, B subtilis, P. aeruginosa, and E. coli, as compared
to the standard drugs [8]. Some compounds of the novel
series of benzothiazolyl thiourea derivatives were equipo-
tent with ampicillin against S. aureus and E. coli and
showed good activity against Mycobacterium tuberculosis
H37Rv. Also, they were evaluated for in vitro cytotoxicity
against MCF-7 breast cancer cells [9].
N-phenyl- and N-benzoylthiourea derivatives obtained
by a simple and inexpensive manner display selective anti-
microbial activities against Cladosporium cladosporioides,
B. subtilis, and Micrococcus luteus. Benzoylthioureas were
more active than the corresponding phenyl ones [10].
5-Thiourea oxazolidinones were synthesized and their
antibacterial activity against Gram-positive bacteria in-
cluding methicillin-resistant S. aureus and vancomycin-
resistant Enterococcus was evaluated. This activity was
significantly affected by the compounds' lipophilicity, es-
pecially the calculated log p value [11].
Medical device-related infections account for a sub-
stantial morbidity, causing an important economic bur-
den by the increase of antibiotic treatment and
hospitalization days, as well as the health-care-
associated costs [12-14]. The topological and chemicalFigure 1 The pathway for the synthesis of the new thioureides (1a, 1characteristics of the medical device surface are influen-
cing microbial adherence, the less likely to be colonized
being the perfectly smooth, hydrophilic ones. A lot of
strategies have been employed to prevent medical
device-related infections, one of them being surface
modification to prevent microbial population and bio-
film formation by (1) the chemical modification of the
surface with protein, (2) the modification of the surface
with quaternary ammonium salts acting as bacteria-
repellent coatings, (3) the incorporation and release of
antibiotics from the surface, and (4) the use of noble
metals and especially silver on the surface as antimicro-
bial coatings [15].
There are a lot of reports on the antimicrobial and
anti-biofilm properties of different types of nanoparti-
cles, especially metals or metallic oxide-containing
ones (silver, copper, gold, and ZnO) [16-26], as well as
core/shell nanosystems (e.g., CoFe2O4/oleic acid,
Fe3O4/oleic acid, and Fe3O4/PEG600) [27-31] that could
be manipulated and improved, potentially providing a
new method for treating antibiotic-resistant device-
related infections [32-35]. In the last year, two articles
were published opening a new perspective for obtain-
ing new antimicrobial and anti-biofilm surfaces, based
on hybrid functionalized nanostructured biomaterials
[36,37]. The first one showed that the Rosmarinus offi-
cinalis essential oil-coated Fe3O4/C18 strongly inhibited
the adherence ability and biofilm development of the
C. albicans and Candida tropicalis tested strains tob).
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usnic acid-coated Fe3O4/C18 strongly inhibited the ad-
herence ability and biofilm development of the S. aur-
eus tested strain to the coverslip surface, as shown by
viable cell counts (VCCs) and confocal laser scanning
microscopy. These material-based approaches to the
control of fungal/microbial adherence could provide
both (1) new tools to study mechanisms of fungal/Figure 2 Schematic illustration of biofilm development in the presenmicrobial virulence and biofilm formation and (2)
approaches to the design of film-coated surfaces or to
treat the surfaces of solid and fiber-based materials that
prevent or disrupt the formation of fungal/microbial
biofilms.
Taking into consideration the aforementioned signifi-
cant antimicrobial activity of thioureas, in order to con-
tinue our work on the evaluation of the bioactivity ofce/absence of the coating nanofluid.
Figure 3 The VVCs of P. aeruginosa cells embedded in biofilms
developed on different catheter sections. C, uncoated catheter;
C +N, catheter coated with nanoparticles; 1a, 1b, catheters
immersed in the compound solution; 1a +N, 1b +N, catheters
coated with N and the chemical compound solution.
Figure 4 The VVCs of S. aureus cells embedded in biofilms
developed on different catheter sections. C, uncoated catheter;
C +N, catheter coated with nanoparticles; 1a, 1b, catheters
immersed in the compound solution; 1a +N, 1b +N, catheters
coated with N and the chemical compound solution.
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a new nanosystem combining new 2-((4-ethylphenoxy)
methyl)-N-(substituted-phenylcarbamothioyl)-benzamides
and a Fe3O4/C12 core/shell nanostructure with up to
5-nm size for catheter surface coating, with an improved
resistance to S. aureus ATCC 25923 and P. aeruginosa
ATCC 27853 colonization and subsequent in vitro biofilm
development.
Methods
Fe3O4/C12: synthesis, characterization, and biological
assay
In a previous study [38], we reported the successful syn-
thesis of magnetite coated with lauric acid (C12) and its
characterization by X-ray diffraction (XRD), transmis-
sion electron microscopy (TEM), thermogravimetric
analysis, and Fourier transform infrared spectroscopy
(FT-IR). The obtained nanopowder was identified as
magnetite by XRD. The dimension of the core/shell
structure not exceeding 5 nm and its spherical shape
were confirmed by TEM analysis. The FT-IR analysis
identified the lauric acid on the surface of the magnetite
nanoparticles. Treatment for 24 h with Fe3O4/C12 is not
cytotoxic on the HEp-2 cell line, this aspect representing
an advantage for the in vivo use of these nanostructures
[38]. Briefly, lauric acid was solubilized in a known vol-
ume of distilled-deionized water, corresponding to a 1%
(w/w) solution, under stirring at room temperature.
Then, a basic aqueous solution consisting of 28% NH3
was added to the lauric acid solution. Thereafter, Fe2+
and Fe3+ (1:2 molar ratio) were dropped under perman-
ent stirring, leading to the formation of a black precipi-
tate. The core/shell was washed with methanol and
separated with a strong NdFeB permanent magnet.
2-((4-Ethylphenoxy)methyl)-N-(substituted-
phenylcarbamothioyl)-benzamides: general synthesis and
characterization
2-((4-Ethylphenoxy)methyl)-N-(phenylcarbamothioyl)-
benzamide (1a) and 2-((4-ethylphenoxy)methyl)-N-
(2-chlorophenylcarbamothioyl)-benzamide (1b) were
prepared according to procedures described by
Limban et al. [39] and according to the scheme plotted in
Figure 1.
The new thioureides (1a, 1b) were prepared by heating
2-((4-ethylphenoxy)methyl)benzoyl isothiocyanate (2)
(obtained from the corresponding chloride (3)) with pri-
mary aromatic amines in dry acetone under reflux. The
acylthioureas are white crystalline solids, insoluble in
water, and soluble in acetone and chloroform at normal
temperature and in short-chain aliphatic alcohols, ben-
zene, toluene, and xylene at higher temperatures. Their
structures were confirmed by elemental analyses, IR, and
NMR spectral data.Fabrication of coating nanofluid
The adsorption shell represented by 15 mg of (1a, 1b) was
solubilized in 1 mL of chloroform together with 135 mg
Fe3O4/C12 nanopowder. This mix was grounded until
complete evaporation of chloroform. This step was
repeated thrice in order to obtain a uniform distribution
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nanostructure. The fabrication was performed by coating
a 1-cm catheter section (the prosthetic device was
obtained from a local provider of ENT Coltea Bucharest
Hospital) with the nanofluid represented by a suspended
core/shell/adsorption shell in CHCl3 (0.33%w/v). The
layer of the nanostructured coating on the catheter sec-
tions was achieved by submerging the catheter pieces in
5 mL of nanofluid aligned in a magnetic field of 100 kgf
applied for 1 s, followed by extemporaneous drying at
room temperature. The rapid drying was facilitated by the
convenient volatility of chloroform. The coated catheter
sections were then sterilized by ultraviolet irradiation for
15 min. Figure 2 presents the schematic illustration of bio-
film development in the presence/absence of the coating
nanofluid.
In vitro microbial biofilm development to the catheter
sections with modified surface
The biofilms were developed using S. aureus ATCC
25923 and P. aeruginosa ATTC 27853 strains. The mi-
crobial adherence ability was investigated in six multi-
well plates, in which there have been placed 1-cm
catheter pieces with and without nanostructured coating.
Plastic wells were filled with a liquid medium, inoculated
with 300 μL of 0.5 McFarland microbial suspensions and
incubated for 72 h at 30°C. After 24 h, the culture
medium was removed, the catheters were washed three
times with phosphate-buffered saline (PBS) in order to
remove the non-adherent strains, and fresh glucose
broth was added. Also, VCCs have been achieved for
both working variants (coated and uncoated catheter
pieces) at 24, 48, and 72 h in order to assess the biofilm-
forming ability of the two strains. The adhered cells have
been removed from the catheter sections by vortexing
and brief sonication, and serial dilutions ranging from
10−1 to 10−4 of the obtained inocula have been spotted
on Muller-Hinton agar, incubated for 24 h at 30°C and
assessed for VCCs.Figure 5 SEM images showing the uncoated catheter surface colonize
biofilm with a rich matrix (left, ×2,500; right, ×5,000).Cell cycle analysis
Plastic slides uncoated or coated with the obtained
nanofluid were put into wells of 3.5-cm diameter, and
thereafter, 3.5 × 105 HCT8 cells and HEp-2 cells were
seeded onto the slides and maintained for 24 h at 37°C
in 5% CO2 and humid condition. The morphology of
cells grown on the plastic or coated slides was checked
using an inverted microscope after 24 h. For cell cycle
analysis, cells were harvested, washed with PBS (pH 7.5),
fixed in 70% cold ethanol, and maintained at −20°C
overnight. Each sample was washed with PBS, treated
with 100 μg/mL RNase A for 15 min, and colored with
10 μg/mL propidium iodide by incubation at 37°C for
1 h. After cell staining with propidium iodide, the acqui-
sition was done using a Coulter Epics XL Flowcytometer
(Fullerton, CA, USA). Data were analyzed using FlowJo
software (Tree Star, Inc., Ashland, OR, USA) and
expressed as fractions of cells in the different cell cycle
phases.Assessment of cytotoxicity by fluorescent microscopy
HCT8 cells (3.5 × 105) were seeded in each well of a 24-
well plate. After 24 h, the cells were treated with 50 μg/
mL of the obtained nanofluid. The effect of the nano-
fluid was evaluated after 24 h by adding 100 μL PI
(0.1 mg/mL) and 100 μL fluorescein diacetate. In order
to evaluate dead cells (red) and viable ones (green),
fluorescence was quantified using a Carl Zeiss Observer.
D1 microscope (Oberkochen, Germany).Statistical analysis
The statistical significance of the obtained results was
analyzed using GraphPad Prism version 5.04 for Win-
dows [40]. We used for comparison the number of
colony-forming units per milliliter as revealed by the
readings of three values/experimental variants. Logarith-
mated values were used for statistical analysis. We chose
to employ two-way ANOVA and Tukey's multipled with S. aureus harvested at 48 h. The images show a mature
Figure 6 SEM images showing compound (1b)-coated catheter surface colonized with S. aureus harvested at 48 h. The images show a
dense biofilm (left, ×2,500; right, ×10,000).
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among the analyzed groups.
Results and discussion
Catheter-related infections continue to be a significant
source of morbidity and mortality in patients requiring
catheterization [41] and increase medical expenses by
prolonging hospitalization. One of the most common eti-
ologies of catheter infections are staphylococci, either
coagulase-negative staphylococci or S. aureus, and P. aer-
uginosa. There are a lot of studies trying to demonstrate
the efficiency of different substances as anti-biofilm-
coated agents in reducing the incidence of catheter-
associated biofilm infections (i.e., cefazolin, teicoplanin,
vancomycin, silver sulfadiazine, chlorhexidine-silver sulfa-
diazine, minocycline-rifampin, lysostaphin, ciprofloxacin,
and protamine sulfate combinations). There are a lot of
studies reporting the efficacy of antibiotic-bonded cathe-
ters in preventing microbial biofilms from developing. It
was demonstrated that the immersion of central venous
catheters and arterial catheters in a 50 mg/mL cefazolin
solution reduced the catheter colonization with Staphylo-
coccus epidermidis from 40% to 2%, proving that antibiotic
bonding is an efficient, safe, and cost-effective method ofFigure 7 SEM images showing nanofluid-coated catheter surface colo
biofilm with rare bacterial cells (left, ×1,500; right, ×10,000).reducing intravascular catheter infections in patients who
are in intensive care units [42,43]. Also, other research
teams demonstrated that catheter coating with lysostaphin
might be more suitable than antimicrobial bonding, due
to the rapid coating time of catheters with minimal on-
site catheter preparation, and the rapidity of kill would
eradicate adherent bacteria within a very short amount of
time, eliminating the risk of infections [44]. Nano-silver
coatings have been applied to several medical devices, of
which catheters, drains, and wound dressings are the most
prominent [15].
Previous studies have demonstrated that the synergism
between ciprofloxacin and protamine sulfate significantly
enhanced the efficacy of ciprofloxacin against planktonic
and biofilm-grown P. aeruginosa cells [45]. In our study,
concerning P. aeruginosa biofilms, catheter coating by
nanoparticles alone proved to be significantly more prone
to bacterial colonization (p < 0.0001) at 24 h than the
standard catheter and the catheter sections either
immersed in the antimicrobial solution or coated with the
nanoparticles loaded with the newly synthesized com-
pounds (Figure 3). The compounds incorporated in nano-
particles (1a) and (1b) proved to be more efficient than
the nanoparticles alone against P. aeruginosa biofilmnized with S. aureus harvested at 48 h. The images show a reduced
Figure 8 Inverted microscope images of HEp-2 cells grown on slides treated with the obtained nanofluid. Phase contrast microscopy,
×200; left, (1a); right, (1b).
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72 h, the compounds incorporated in nanoparticles (1a)
exhibited a very significant improvement of the anti-
biofilm activity as compared with the catheter sections
immersed in the soluble compound (1a) (p< 0.0001).
Concerning S. aureus biofilms, at 24 h, as for the case of
P. aeruginosa biofilms, the catheters coated only with
nanoparticles were significantly more colonized as com-
pared with the uncoated catheter (p < 0.0001; Figure 4).
However, compound (1a) exhibited a strong anti-biofilm
activity, the results being very significant when comparing
either the uncoated catheter versus the catheter immersed
in the soluble compound (p < 0.0001) or the catheter
coated with nanoparticles versus the catheter coated with
nanoparticles and compound (1a) (p < 0.0001).
At 48 h, both compounds (1a) and (1b) in soluble
form exhibited protective activity against S. aureus ma-
ture biofilm development (p < 0.0001). Only compound
(1b) significantly improved the anti-biofilm of the cath-
eter surface in the presence of nanoparticles (p < 0.0001).
Very statistically significant results have been obtained
at 72 h when a strong inhibitory effect of S. aureusFigure 9 HCT8 cell cycle analysis after 24-h development on microsco
(1a), (1b), and control.biofilm development was obtained for the catheter coat-
ing constituted of nanoparticles loaded with compounds
(1a) and (1b), as compared with the results obtained for
the catheter sections immersed in the compound solu-
tion alone or coated only with nanoparticles (p < 0.0001).
Our results are demonstrating that the nanoparticle
layer alone is not protective against microbial
colonization, probably affecting the roughness and the
electric charge of the catheter surface, favoring the inter-
action with the microbial surfaces. On the other hand,
our study is clearly proving that the nanoparticle layer is
interacting differently with the incorporated substances,
influencing their release time in active forms and their
antimicrobial activity.
The coating system represented by nanoparticles loaded
with (1a) proved to be efficient in preventing both the ini-
tial formation as well the development of mature micro-
bial biofilms formed by S. aureus and P. aeruginosa,
demonstrating the efficiency of the nanoparticle coating in
the delivery of the chemical compound in active forms for
a long period of time. These results are also proving that
the obtained nanostructured coating agent is not onlypic slides coated with the obtained nanofluid. From left to right:
Figure 10 The effects of the obtained nanofluids on HCT8 cell viability. IF, ×200; left, (1a); right, (1b).
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also acting as a biofilm dispersal agent. The molecular
mechanisms of bacterial biofilm dispersal are only begin-
ning to be elucidated; however, biofilm dispersal is a
promising area of research that may lead to the develop-
ment of novel agents that inhibit biofilm formation or
promote biofilm cell detachment. Such agents may be use-
ful for the prevention and treatment of biofilms in a var-
iety of industrial and clinical settings [46].
Scanning electron microscopy (SEM) was used for
the evaluation of catheter surface, detection of bio-
film, and studying the effect of the coating agents on
biofilm development. This technique provides excel-
lent visualization of glycocalyx, which is one of the
most prominent features of biofilms and a crucial re-
search subject in searching for alternative antimicro-
bial and anti-adherent agent treatment [47]. After 24,
48, and 72 h of incubation, the samples were
removed from the plastic wells, washed three times
with PBS, fixed with cold methanol, and dried before
microscopic examination. The samples were visualized
using a HITACHI S2600N electron microscope
(Chiyoda-ku, Japan), at 25 keV, in primary electron
fascicle, on samples covered with a thin silver layer.
The culture-based findings were substantiated by the
SEM studies of colonized catheter samples, showing
the gradual decrease of microbial colonization from
the uncoated catheter to the catheter pieces immersed
in the compound solution to the catheter pelliculized
with nanofluids (nanoparticles and compound solu-
tion; Figures 5, 6, and 7).
When HEp-2 cells were grown on slides coated with
the obtained nanofluid, containing nanoparticles and
compounds (1a) and (1b), no changes were observed in
their morphology (Figure 8). The analysis of the cell
cycle of HEp-2 cells grown on slides coated with
nanofluid showed no significant changes of cell cycle
phases (Figure 9). Only unsignificant cell death rate
was induced by a concentration of 50 μg/mL
(Figure 10).Conclusions
Our aim was to combine the unique properties of newly
synthesized biocompatible Fe3O4/C12 nanoparticles with
2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarba-
mothioyl)-benzamides in order to obtain functionalized
catheter surfaces with improved resistance to in vitro
microbial colonization and biofilm development. The
obtained nanofluids proved to be not cytotoxic and did
not influence the eukaryotic cell cycle. The long-lasting
efficacy of compound (1a) loaded on nanoparticles could
be regarded as a future solution to provide persistent,
broad-spectrum antibacterial effects with minimal side
effects. Taken together, our results could be of a great
interest for the biomedical field, opening new directions
for the design of film-coated surfaces with improved
anti-biofilm properties.
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